塞普特纳生物
SEPN
36.35
-1.10
-2.94%
塞普特纳生物
US · SEPN
#2886 按市值排名
上市于 2024
36.35
-1.10
-2.94%
实时 - 追踪5344个代码 - 心跳于78秒前
· 2026-10-16 19:30
最新新闻
-
评级变动
Analysts Offer Insights on NA Companies: Septerna, Inc. (SEPN) and Rapid7 (RPD)TipRanks · 2026/8/11
-
评级变动
H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $60\u5e02\u573a\u8d44\u8baf · 2026/8/13
-
评级变动
Analysts Conflicted on These NA Names: Septerna, Inc. (SEPN) and Douglas AG (OtherDOUDF)TipRanks · 2026/8/12
-
评级变动
Cantor Fitzgerald Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $60\u5e02\u573a\u8d44\u8baf · 2026/8/11
-
评级变动
H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $40\u5e02\u573a\u8d44\u8baf · 2026/7/1
-
评级变动
Cantor Fitzgerald Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $60\u5e02\u573a\u8d44\u8baf · 2026/6/30
-
评级变动
Septerna, Inc. (SEPN) Receives a Rating Update From a Top AnalystTipRanks · 2026/8/17
-
Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), Septerna, Inc. (SEPN) and TWFG, Inc. Class A (TWFG)TipRanks · 2026/8/19
-
Wells Fargo Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $50\u5e02\u573a\u8d44\u8baf · 2026/9/10
-
评级变动
Guggenheim Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $51\u5e02\u573a\u8d44\u8baf · 2026/8/11
-
Truist Financial Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $59\u5e02\u573a\u8d44\u8baf · 2026/8/14
-
J.P. Morgan Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $48\u5e02\u573a\u8d44\u8baf · 2026/8/19
-
评级变动
Wells Fargo Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $50\u5e02\u573a\u8d44\u8baf · 2026/8/12
-
评级变动
Stifel Maintains Septerna(SEPN.US) With Buy Rating, Cuts Target Price to $46\u5e02\u573a\u8d44\u8baf · 2026/8/17
-
评级变动
Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR)TipRanks · 2026/7/1
-
评级变动
A Quick Look at Today's Ratings for Septerna(SEPN.US), With a Forecast Between $49 to $60\u5e02\u573a\u8d44\u8baf · 2026/8/12
-
评级变动
Stifel Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $49\u5e02\u573a\u8d44\u8baf · 2026/8/13
-
评级变动
Analysts Offer Insights on NA Companies: MBX Biosciences, Inc. (MBX), Septerna, Inc. (SEPN) and Six Flags Entertainment Corporation (FUN)TipRanks · 2026/8/13
-
评级变动
Truist Financial Maintains Septerna(SEPN.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/6/30
-
Wells Fargo Sticks to Their Buy Rating for Septerna, Inc. (SEPN)TipRanks · 2026/9/10
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
塞普特纳生物 讨论区 0 条评论